0.1801
Precedente Chiudi:
$0.1781
Aprire:
$0.1779
Volume 24 ore:
542.96K
Relative Volume:
0.05
Capitalizzazione di mercato:
$10.91M
Reddito:
$7,500
Utile/perdita netta:
$-10.96M
Rapporto P/E:
-0.0785
EPS:
-2.2943
Flusso di cassa netto:
$-11.41M
1 W Prestazione:
+0.06%
1M Prestazione:
+28.64%
6M Prestazione:
-12.15%
1 anno Prestazione:
-76.64%
Azitra Inc Stock (AZTR) Company Profile
Nome
Azitra Inc
Settore
Industria
Telefono
203 646 6446
Indirizzo
21 Business Park Drive, Branford
Compare AZTR vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
AZTR
Azitra Inc
|
0.1801 | 10.79M | 7,500 | -10.96M | -11.41M | -2.2943 |
|
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
|
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Azitra Inc Borsa (AZTR) Ultime notizie
Why Is AZTR Stock Rising Today? - Stocktwits
Azitra to Present Corporate Update at Investment Conference - TipRanks
Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire
AZTR News | AZITRA INC (NYSEARCA:AZTR) - ChartMill
Azitra Inc (AZTR) Holds at $0.17 as Tight Range Between $0.16 Support and $0.18 Resistance PersistsFibonacci Extension - dars.gov.et
Azitra Inc (AZTR) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Azitra (AZTR) Trading: Closes 13.25% Higher at $0.15; Immediate View: the Near-Term Reference Band Stretches From $0.14 to $0.16 under the Current SnapshotFibonacci Entry Signals - vinanet.vn
Azitra (AZTR) Levels: Finishes 4.81% Higher at $0.13 in the Current Update; Range Check - vinanet.vn
Azitra Regains NYSE American Listing Compliance Status - The Globe and Mail
Azitra (NYSE:AZTR) Strengthens Market Position After Listing Milestone - Kalkine Media
Branford bioscience firm regains NYSE compliance - Hartford Business Journal
Azitra regains compliance with NYSE American listing standards - Investing.com
Azitra regains compliance with NYSE American li... - Pluang
Azitra Regains NYSE American Compliance; .BC Indicator to Be Removed - TradingView
Azitra (NYSE: AZTR) wins back listing under new NYSE watch period - Stock Titan
Azitra regains compliance with NYSE American listing standards By Investing.com - Investing.com UK
Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards - PR Newswire
Azitra (AZTR) Earnings Comparison: The Bottom-Line Figure Trails Its Comparison in the Available Record; Post-Report Move: Shares Fall 7.61% in the Latest ReadingROA Comparison - vinanet.vn
Azitra (AZTR): Nantahala Capital reports 6.48M-share, 9.99% beneficial stake - Stock Titan
Nantahala Capital Partners (AZTR) discloses 8.40% beneficial stake in Azitra - Stock Titan
Azitra, Inc. (AZTR) stock price, news, quote and history - Yahoo Finance Australia
Azitra Reports Q2 Net Loss of $3.3 Million - Quiver Quantitative
Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates - PR Newswire
Azitra (NYSE American: AZTR) posts Q2 2026 loss but lifts equity above NYSE limits - Stock Titan
Azitra, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Azitra reports Q2 2026 results, advances skin t... - Pluang
Azitra Inc (AZTR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AZTR Q1 2026 Earnings: EPS Misses Estimates Sharply; No Revenue ReportedProfitability Analysis - vinanet.vn
Azitra Inc (AZTR) Stock News Today - TradingKey
AZTR|Azitra Inc|Price:0.133|Chg%:+0.002 - TradingKey
Azitra Inc Q1 2026 Earnings: Deep EPS Miss Raises Concern as Revenue Remains AbsentBalance Sheet Strength - vinanet.vn
Azitra’s ATR12-351 Trial Completion Puts Rare-Disease Skin Drug on Investors’ Radar - TipRanks
AZTR Q1 2026 Earnings: Clinical-stage biotech posts wider-than-expected loss, shares declineRevenue Growth Report - vinanet.vn
Azitra Inc (AZTR) Income Statement - TradingKey
Azitra Inc Revenue Breakdown – AMEX:AZTR - TradingView
Azitra Inc (AZTR) Cash Flow - TradingKey
AZTR|Azitra Inc|Price:0.130|Chg%:+0.003 - TradingKey
Azitra Inc (AZTR) Balance Sheet - tradingkey.com
Azitra Inc (AZTR) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Azitra Inc (AZTR) Institutional Confidence - TradingKey
Azitra Inc (AZTR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Azitra Inc (AZTR) Tests Key Support at $0.12 After Modest DeclineRSI Overbought Alerts - dars.gov.et
Azitra Inc (AZTR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Azitra Inc (AZTR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Azitra Inc (AZTR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Azitra Inc (AZTR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Azitra Inc (AZTR) Earnings Date & Reports & Earnings News - TradingKey
AZTR Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Development Costs WeighGrowth Acceleration Report - vinanet.vn
AZTR Q1 2026 Earnings: Massive EPS Miss as Clinical-Stage Biotech Reports Wider LossAnnual Financial Report - vinanet.vn
Azitra Inc. (AZTR) surges over 44% after hours—here's why it's trending - MSN
Enterprise value to EBIT forward of Azitra Inc – AMEX:AZTR - TradingView
Azitra Inc Azioni (AZTR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Capitalizzazione:
|
Volume (24 ore):